Global Patent Index - EP 1100917 A1

EP 1100917 A1 2001-05-23 - GRANULOCYTIC EHRLICHIA GENES AND USES THEREOF

Title (en)

GRANULOCYTIC EHRLICHIA GENES AND USES THEREOF

Title (de)

GRANULOCYTIC EHRLICHIA GENEN UND IHRE VERWENDUNGEN

Title (fr)

GENES D'EHRLICHIA GRANULOCYTE ET LEURS UTILISATIONS

Publication

EP 1100917 A1 (EN)

Application

EP 98955088 A

Priority

  • US 9822512 W
  • US 9438198 P

Abstract (en)

[origin: WO0006744A1] The present invention relates, in general, to granulocytic ehrlichia (GE) proteins. In particular, the present invention relates to nucleic acid molecules coding for WI1, WI2, WI3, WI4, WIC, NY1, NY2, NY3, SWED, BOV, EQ, SLOV1, and SLOV2 proteins; purified WI1, WI2, WI3, WI4, WIC, NY1, NY2, NY3, SWED, BOV, EQ, SLOV1, and SLOV2 proteins and polypeptides; recombinant nucleic acid molecules; cells containing the recombinant nucleic acid molecules; antibodies having binding affinity specifically to WI1, WI2, WI3, WI4, WIC, NY1, NY2, NY3, SWED, BOV, EQ, SLOV1, and SLOV2 proteins and polypeptides; hybridomas containing the antibodies; nucleic acid probes for the detection of nucleic acids encoding WI1, WI2, WI3, WI4, WIC, NY1, NY2, NY3, SWED, BOV, EQ, SLOV1, and SLOV2 proteins; a method of detecting nucleic acids encoding WI1, WI2, WI3, WI4, WIC, NY1, NY2, NY3, SWED, BOV, EQ, SLOV1, and SLOV2 proteins or polypeptides in the sample; kits containing nucleic acid probes or antibodies; bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess, or prognose a mammal afflicted with ehrlichiosis; therapeutic uses, specifically vaccines comprising proteins, polypeptides or nucleic acids; and methods of preventing or inhibiting ehrlichiosis in an animal.

IPC 1-7 (main, further and additional classification)

C12N 15/31; C07K 14/29; C12Q 1/68; G01N 33/68; A61K 38/16; A01K 67/027; A61K 39/02

IPC 8 full level (invention and additional information)

A01K 67/027 (2006.01); A61K 39/00 (2006.01); A61P 31/00 (2006.01); C07K 14/195 (2006.01); C07K 14/29 (2006.01); C07K 16/12 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/31 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/569 (2006.01); G01N 33/577 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C07K 14/29 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); Y02A 50/403 (2018.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0006744 A1 20000210; AU 1197799 A 20000221; CA 2340855 A1 20000210; EP 1100917 A1 20010523; JP 2002527042 A 20020827

INPADOC legal status


2003-11-05 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20030503

2001-05-23 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010226

2001-05-23 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE